Opus Regulatory Inc.
Sheila Bello is a seasoned expert in regulatory affairs strategy, currently serving as Principal Consultant at Opus Regulatory Inc. since February 2025. Previous experience includes the role of Director of Regulatory Affairs Strategy at AstraZeneca, where leadership was provided for monoclonal antibody programs within the infectious disease therapeutic area. Sheila's background also encompasses significant positions at NOVAVAX INC and UCB, focusing on global regulatory strategies and submission planning for vaccine products. Sheila’s early career involved overseeing regulatory submission projects at MMS. Academic credentials include a PhD and MS in Microbiology and Immunology from the University of Rochester School of Medicine and Dentistry and the University of Rochester, respectively.
This person is not in any teams
This person is not in any offices